Our Commitment to nanomedecine
One in four deaths in the U.S. is from cancer, making it the second-leading cause of death after heart attack.
NanoXray offers a dramatic innovation in cancer therapy, based on a technology that is designed to allow destruction of cancer cells by inert particles.
NanoXray thus offers a new treatment weapon that could be used alone, or in concert with existing anticancer protocols: chemotherapy, surgery, targeted molecules, and immunotherapy.
NanoXray compounds are intended to be activated from outside the body with a conventional Xray, after injection. And, efficacy is expected to be proportional to the duration of activation and the number of radiotherapy sessions.
Taking into account the mechanism of action of nanoXray, it is expected that administration of nanoXray will not have to be chronic, thus preventing the risk of an immune response and toxicity by accumulation.
Indeed, use of nontoxic nanoXray compounds should decrease the risk of adverse events, allowing the production of higher doses of free radicals leading to superior anticancer activity.